Peak Bggr17 hours agoOnline orders begin for first over-the-counter birth control pill in the USverified_publisherCNNCNN — The rollout is underway for Opill, the first over-the-counter birth control pill approved in the United States, and online sales began Monday morning. Consumers can start ordering Opill online Monday, and orders will be fulfilled within a day or two, Sara Young, senior vice president and chief …
Peak Bggr14 hours agoChinese biotech's MASH candidate reduces liver fat in phase 2 trialfiercebiotech.com - Max BayerChipscreen Biosciences' metabolic dysfunction-associated steatohepatitis (MASH) candidate reduced patients' liver fat levels, adding further momentum …
Peak Bggr19 hours agoJ&J-allied Contineum files for IPO to take fight to BMS, Roche and morefiercebiotech.com - ntaylorJ&J-allied Contineum files for IPO to take fight to BMS, Roche and more ntaylor Mon, 03/18/2024 - 06:27
Peak Bggr1 day agoJ&J-Backed Contineum Unveils IPO Plans to Advance MS Pipeline | BioSpacebiospace.comPictured: Nasdaq Stock Exchange building in New York City/iStock, JHVEPhoto Contineum Therapeutics on Friday filed for an initial public offering, …
Peak Bggr1 day agoMadrigal’s Rezdiffra Energizes MASH Space, Sets Bar for Future Therapies | BioSpacebiospace.comPictured: Illustration of a liver with signs of fibrosis/iStock, Mohammed Haneefa Nizamudeen The approval of Madrigal Pharmaceuticals’ Rezdiffra …
Peak Bggr9 hours agoGenetic Testing Stock Nears Buy Point After Earnings Gap-Up And 45% Gaininvestors.com - VIDYA RAMAKRISHNANHealth care stocks have been on a run and some are near buy points. Natera (NTRA), a genetic testing company, is one example of that, and so it is …